CFD 属于复杂的高风险金融工具，其杠杆作用可能导致投资者迅速亏损。 84% 的散户投资者因进行 CFD 交易遭受资金损失。 请您谨慎考虑自己是否了解 CFD 操作，以及是否能够接受高额亏损的风险。
US 简体中文
國家 • United States
    實體 • The products and services listed on this website are not available in this location.
    English العَرَبِيَّة Bahasa Indonesia Български Čeština Dansk Deutsch Eesti ελληνικά Español Français Hrvatski Italiano Latviešu Lietuvių Magyar Nederlands Polski Português Română Русский Slovenčina Slovenščina Suomi Svenska Tiếng Việt ไทย 简体中文 繁體中文

    交易 Citius Pharmaceuticals, Inc. - CTXR CFD

    1.2361
    7.82%
    0.0278
    最低: 1.1464
    最高: 1.286
    Market Trading Hours* (UTC) Opens on Friday at 13:30

    Mon - Fri: 13:30 - 20:00

    • 概括
    • 历史数据
    • 活动
    • 收入报表
    • 资产负债表
    • 现金流
    • 所有权
    交易条件
    价差 0.0278
    多头隔夜费

    Long position overnight fee

    Margin. Your investment $1,000.00
    隔夜费用 -0.025457 %
    Charges from borrowed part ($-1.02)
    Trade size with leverage ~ $5,000.00
    Money from leverage ~ $4,000.00
    前往平台
    		-0.025457%
    空头隔夜费

    Short position overnight fee

    Margin. Your investment $1,000.00
    隔夜费用 0.003235 %
    Charges from borrowed part ($0.13)
    Trade size with leverage ~ $5,000.00
    Money from leverage ~ $4,000.00
    前往平台
    		0.003235%
    隔夜费时间 21:00 (UTC)
    最小交易量 1
    货币 USD
    保证金 20%
    上市交易所 United States of America
    交易费 0%

    *Information provided by Capital.com

    Citius Pharmaceuticals Inc ESG Risk Ratings

    High Medium Low Negligible

    ‘D’ score indicates poor relative ESG performance and insufficient degree of transparency in reporting material ESG data publicly.

    关键数据
    前收盘价* 1.1464
    开仓* 1.1464
    1 年变化* 25.98%
    日范围* 1.1464 - 1.286
    52 周范围 0.77-1.71
    平均交易量（10 天） 1.57M
    平均交易量（3 个月) 29.46M
    市值 174.74M
    市盈率 -100.00K
    流通股 158.86M
    收入 N/A
    EPS -0.21
    股息（收益率 %） N/A
    贝塔 1.38
    下一个财报发布日期 Aug 9, 2023

    所有数据都是由Refinitiv提供的， 除了标有星号的数据， 这是*由 Capital.com 提供的数据

    • Last Week
    • Last Month
    • Last Year
    • Last two Years
    • Max
    • Daily
    • Weekly
    • Monthly
    Date 平仓 Change Change (%) 開倉 High Low
    May 31, 2023 1.1364 0.0399 3.64% 1.0965 1.1464 1.0965
    May 30, 2023 1.0965 -0.0100 -0.90% 1.1065 1.1364 1.0965
    May 26, 2023 1.1065 0.0299 2.78% 1.0766 1.1165 1.0766
    May 25, 2023 1.0766 -0.0498 -4.42% 1.1264 1.1264 1.0666
    May 24, 2023 1.1065 0.0200 1.84% 1.0865 1.1364 1.0666
    May 23, 2023 1.0965 -0.0299 -2.65% 1.1264 1.1464 1.0666
    May 22, 2023 1.1264 -0.0399 -3.42% 1.1663 1.1763 1.1264
    May 19, 2023 1.1663 0.0199 1.74% 1.1464 1.1763 1.1264
    May 18, 2023 1.1165 0.0100 0.90% 1.1065 1.1564 1.0866
    May 17, 2023 1.0866 -0.1694 -13.49% 1.2560 1.2561 1.0467
    May 16, 2023 1.2461 0.0000 0.00% 1.2461 1.2660 1.2261
    May 15, 2023 1.2660 -0.1296 -9.29% 1.3956 1.4056 1.2261
    May 12, 2023 1.3956 0.0498 3.70% 1.3458 1.4355 1.2860
    May 11, 2023 1.2959 0.0199 1.56% 1.2760 1.4355 1.2760
    May 10, 2023 1.2461 0.0100 0.81% 1.2361 1.2860 1.1962
    May 9, 2023 1.2261 -0.0399 -3.15% 1.2660 1.2760 1.2261
    May 8, 2023 1.2660 -0.0100 -0.78% 1.2760 1.2959 1.2461
    May 5, 2023 1.2660 0.0000 0.00% 1.2660 1.2959 1.2361
    May 4, 2023 1.2461 -0.0997 -7.41% 1.3458 1.3857 1.1962
    May 3, 2023 1.4854 -0.0099 -0.66% 1.4953 1.5053 1.4654

    Citius Pharmaceuticals, Inc. Events

    时间（协调世界时） (UTC) 国家/地区 事件
    Wednesday, August 9, 2023

    时间（协调世界时） (UTC)

    10:59

    国家/地区

    US

    事件

    Q3 2023 Citius Pharmaceuticals Inc Earnings Release
    Q3 2023 Citius Pharmaceuticals Inc Earnings Release

    Forecast

    -

    Previous

    -
    查看所有活動
    • 年度
    • 每季度
    2022 2021 2020 2019 2018
    总收入 0 0 0 0 0
    收入 0 0 0 0 0
    总营业费用 33.3161 23.3653 17.7107 15.5984 13.3391
    销售/一般/行政费用，总计 15.6606 11.2914 8.89788 7.00146 7.22622
    研究与开发 17.6555 12.2405 8.81281 8.5969 6.56293
    营业收入 -33.3161 -23.3653 -17.7107 -15.5984 -13.3391
    利息收入（费用），非经营净值 0.2514 0.25099 0.0524 0.03622 -0.01584
    税前净收入 -33.0647 -23.0544 -17.5481 -15.5621 -12.5366
    税后净收入 -33.6407 -23.0544 -17.5481 -15.5621 -12.5366
    未计算非常项目前的净收益 -33.6407 -23.0544 -17.5481 -15.5621 -12.5366
    净收入 -33.6407 -23.0544 -17.5481 -15.5621 -12.5366
    普通股股东可获收益 (不含非经常性项目) -33.6407 -24.5053 -17.5481 -15.5621 -12.5366
    普通股股东可获收益 (含非經常性項目) -33.6407 -24.5053 -17.5481 -15.5621 -12.5366
    摊薄净收入 -33.6407 -24.5053 -17.5481 -15.5621 -12.5366
    摊薄后加权平均股 146.082 108.599 39.1652 20.1618 10.7319
    扣除特别项目的每股摊薄盈利 -0.23029 -0.22565 -0.44805 -0.77186 -1.16817
    每股正常摊薄盈利 -0.23029 -0.22718 -0.44805 -0.77186 -1.2101
    异常费用（收入） 0 -0.16656 0 -0.45
    其他，净值 0 0.05992 0.11021 0 0.81834
    Total Adjustments to Net Income 0 -1.45088
    Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
    总收入 0 0 0 0 0
    收入 0 0 0 0 0
    总营业费用 10.6853 3.66419 7.54957 8.91665 7.59063
    销售/一般/行政费用，总计 5.95845 3.80437 3.69234 4.02846 4.13842
    研究与开发 4.72686 3.44552 3.85723 4.88819 3.45221
    营业收入 -10.6853 -3.66419 -7.54957 -8.91665 -7.59063
    利息收入（费用），非经营净值 0.30328 0.21455 0.13483 0.05302 0.02957
    其他，净值 0 0
    税前净收入 -10.382 -3.44965 -7.41474 -8.86363 -7.56105
    税后净收入 -10.526 -3.59365 -7.99074 -8.86363 -7.56105
    未计算非常项目前的净收益 -10.526 -3.59365 -7.99074 -8.86363 -7.56105
    净收入 -10.526 -3.59365 -7.99074 -8.86363 -7.56105
    普通股股东可获收益 (不含非经常性项目) -10.526 -3.59365 -7.99074 -8.86363 -7.56105
    普通股股东可获收益 (含非經常性項目) -10.526 -3.59365 -7.99074 -8.86363 -7.56105
    摊薄净收入 -10.526 -3.59365 -7.99074 -8.86363 -7.56105
    摊薄后加权平均股 146.252 146.211 146.146 146.13 146.042
    扣除特别项目的每股摊薄盈利 -0.07197 -0.02458 -0.05468 -0.06066 -0.05177
    Dividends per Share - Common Stock Primary Issue 0 0 0 0
    每股正常摊薄盈利 -0.07197 -0.04052 -0.05468 -0.06066 -0.05177
    Total Adjustments to Net Income 0 0
    异常费用（收入） 0 -3.58569 0
    • 年度
    • 每季度
    2022 2021 2020 2019 2018
    流动资产总额 44.5643 72.8143 13.982 7.94192 10.0601
    现金和短期投资 41.7117 70.073 13.8597 7.8938 9.184
    现金等价物 41.7117 70.073 13.8597 7.8938 9.184
    Prepaid Expenses 2.85258 2.7414 0.12224 0.04811 0.05773
    Total Assets 113.999 142.429 43.7737 36.7464 31.0505
    Property/Plant/Equipment, Total - Net 0.65017 0.82985 0.98778 0.00059 0.00148
    Property/Plant/Equipment, Total - Gross
    Accumulated Depreciation, Total
    Goodwill, Net 9.3468 9.3468 9.3468 9.3468 1.5868
    Intangibles, Net 59.4 59.4 19.4 19.4 19.4
    Other Long Term Assets, Total 0.03806 0.03806 0.05709 0.05709 0.00217
    Total Current Liabilities 4.53001 3.98229 4.09713 4.60772 3.18484
    Accounts Payable 1.16538 1.2771 1.85624 2.71354 1.57344
    Accrued Expenses 3.36463 2.7052 2.06793 1.72121 1.43843
    Notes Payable/Short Term Debt 0 0 0.17297 0.17297 0.17297
    Other Current Liabilities, Total 0
    Total Liabilities 11.1734 10.2467 10.103 9.59352 3.18484
    Total Long Term Debt 0 0 0.16458 0 0
    Total Equity 102.826 132.182 33.6707 27.1529 27.8657
    Preferred Stock - Non Redeemable, Net 0 0 0
    Common Stock 0.14621 0.14598 0.05558 0.02893 0.0162
    Additional Paid-In Capital 232.368 228.084 104.209 80.1697 68.1073
    Retained Earnings (Accumulated Deficit) -129.688 -96.0478 -70.5939 -53.0458 -40.2578
    Total Liabilities & Shareholders’ Equity 113.999 142.429 43.7737 36.7464 31.0505
    Total Common Shares Outstanding 146.211 145.979 55.577 28.9305 16.1988
    应收账款总额，净额 0.81834
    Long Term Debt 0 0.16458 0
    Deferred Income Tax 5.5618 4.9858 4.9858 4.9858
    Other Liabilities, Total 0.48125 0.67823 0.85547
    Minority Interest 0.60038 0.60038
    Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
    流动资产总额 34.9011 42.3174 44.5643 50.8345 58.2593
    现金和短期投资 29.0655 36.8872 41.7117 48.0442 55.7562
    现金等价物 29.0655 36.8872 41.7117 48.0442 55.7562
    Prepaid Expenses 5.8356 5.43013 2.85258 2.79032 2.50311
    Total Assets 104.241 111.705 113.999 120.316 127.786
    Property/Plant/Equipment, Total - Net 0.55484 0.60299 0.65017 0.69642 0.74177
    Goodwill, Net 9.3468 9.3468 9.3468 9.3468 9.3468
    Intangibles, Net 59.4 59.4 59.4 59.4 59.4
    Other Long Term Assets, Total 0.03806 0.03806 0.03806 0.03806 0.03806
    Total Current Liabilities 6.20968 4.53717 4.53001 4.46112 4.02192
    Accounts Payable 2.72559 1.53758 1.16538 1.69052 1.70513
    Accrued Expenses 3.48408 2.99959 3.36463 2.7706 2.3168
    Notes Payable/Short Term Debt 0 0 0 0 0
    Total Liabilities 13.0347 11.2719 11.1734 10.5802 10.1904
    Total Long Term Debt 0 0 0 0 0
    Long Term Debt
    Deferred Income Tax 5.8498 5.7058 5.5618 4.9858 4.9858
    Minority Interest 0.60038 0.60038 0.60038 0.60038 0.60038
    Other Liabilities, Total 0.37483 0.42857 0.48125 0.53288 0.5823
    Total Equity 91.2061 100.433 102.826 109.736 117.596
    Preferred Stock - Non Redeemable, Net 0 0 0 0
    Common Stock 0.14636 0.14621 0.14621 0.14613 0.14613
    Additional Paid-In Capital 234.868 233.569 232.368 231.287 230.284
    Retained Earnings (Accumulated Deficit) -143.808 -133.282 -129.688 -121.698 -112.834
    Total Liabilities & Shareholders’ Equity 104.241 111.705 113.999 120.316 127.786
    Total Common Shares Outstanding 146.358 146.211 146.211 146.13 146.13
    • 年度
    • 每季度
    2022 2021 2020 2019 2018
    净收入/起跑线 -33.6407 -23.0544 -17.5481 -15.5621 -12.5366
    经营活动产生的现金 -28.3613 -24.2504 -16.9307 -12.4377 -11.3181
    经营活动产生的现金 0.00292 0.00149 0.00084 0.00089 0.00175
    非现金物品 4.46091 1.5198 1.48355 0.92758 0.7069
    Cash Taxes Paid
    已付现金利息 0 0.00019
    营运资金的变化 0.23956 -2.71727 -0.86697 2.19592 0.50985
    投资活动产生的现金 0 -40.0069 -0.00183 0 0
    其他投资现金流量项目，总计 0
    融资活动产生的现金 0 120.471 22.8984 11.1475 17.298
    融资现金流项目 0 18.4504 0 0
    债务的发行（退还），净额 0 -0.17297 0.16458 0 0
    现金净变化 -28.3613 56.2132 5.96594 -1.2902 5.9799
    资本支出 0 -40.0069 -0.00183 0 0
    股票的发行（报废），净额 0 102.193 22.7339 11.1475 17.298
    Deferred Taxes 0.576
    Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
    Net income/Starting Line -14.1197 -3.59365 -33.6407 -25.6499 -16.7863
    Cash From Operating Activities -12.6774 -4.82444 -28.3613 -22.0287 -14.3167
    Cash From Operating Activities 0.00146 0.00073 0.00292 0.00219 0.00146
    Non-Cash Items 2.56255 1.24754 4.46091 3.3344 2.28611
    Changes in Working Capital -1.40977 -2.62306 0.23956 0.28456 0.18199
    Cash From Financing Activities 0.03127 0 0 0 0
    Financing Cash Flow Items 0 0 0 0
    Issuance (Retirement) of Stock, Net 0.03127 0 0 0
    Issuance (Retirement) of Debt, Net 0 0 0
    Net Change in Cash -12.6462 -4.82444 -28.3613 -22.0287 -14.3167
    Cash From Investing Activities 0 0 0
    Capital Expenditures 0 0
    Deferred Taxes 0.288 0.144 0.576
    Other Investing Cash Flow Items, Total 0
    投资者名称 投资者类型 流通股百分比 持有股份 股份变动 持有日期 换手率
    Mazur (Leonard L) Individual Investor 6.4557 10255342 -1 2022-11-30 LOW
    The Vanguard Group, Inc. Investment Advisor/Hedge Fund 3.8112 6054328 40301 2023-03-31 LOW
    Armistice Capital LLC Hedge Fund 1.5265 2425000 -3743361 2021-12-31 HIGH
    BlackRock Institutional Trust Company, N.A. Investment Advisor 1.4586 2317168 4868 2023-03-31 LOW
    Holubiak (Myron Z) Individual Investor 1.2541 1992243 0 2022-11-30
    Geode Capital Management, L.L.C. Investment Advisor/Hedge Fund 0.8428 1338777 6154 2023-03-31 LOW
    State Street Global Advisors (US) Investment Advisor/Hedge Fund 0.3 476597 34000 2023-03-31 LOW
    Susquehanna International Group, LLP Investment Advisor 0.2893 459511 130223 2023-03-31 MED
    GSA Capital Partners LLP Hedge Fund 0.2849 452561 -46222 2023-03-31 LOW
    Renaissance Technologies LLC Hedge Fund 0.2513 399270 -9900 2023-03-31 HIGH
    Millennium Management LLC Hedge Fund 0.1917 304482 -246644 2023-03-31 HIGH
    Jane Street Capital, L.L.C. Research Firm 0.1549 246023 224990 2023-03-31 HIGH
    Northern Trust Investments, Inc. Investment Advisor/Hedge Fund 0.1541 244755 7008 2023-03-31 LOW
    Hightower Advisors, LLC Investment Advisor 0.1317 209198 14713 2023-03-31 LOW
    Inspire Advisors, LLC Investment Advisor 0.125 198632 2686 2023-03-31 LOW
    Wealth Advisory Solutions, L.L.C. Investment Advisor 0.0981 155850 0 2023-03-31 MED
    AHL Partners LLP Investment Advisor 0.0836 132826 86615 2023-03-31 HIGH
    Morgan Stanley & Co. LLC Research Firm 0.0759 120521 31943 2023-03-31 MED
    Qube Research & Technologies Ltd Hedge Fund 0.063 100106 -20474 2023-03-31 HIGH
    Kestra Advisory Services, LLC Investment Advisor 0.0579 91917 -1800 2023-03-31 MED

    为什么选择 Capital.com？让我们的数字来说话。

    Capital.com Group

    535K+

    交易者

    87K+

    每月活跃客户

    $113M+

    每月投资额

    $64M+

    每月提取金额

    交易计算器

    如果您在特定日期（选择一个日期）开立差价合约交易并在不同日期（选择一个日期）关闭交易，计算您的假设盈亏。

    交易佣金
    0
    • 1:1
    杠杆
    1:1
    • 20
    • 100
    • 500
    • 1000
    • 10000
    投资
    交易规模（杠杆 x 投资）：
    開倉

    平仓

    做空 做多
    過去的表現並不是未來結果的可靠指標
    盈利/盈利/亏损

    Citius Pharmaceuticals, Inc. Company profile

    关于 Citius Pharmaceuticals Inc

    Citius Pharmaceuticals Inc.专业制药公司。 该公司开发和商业化重症监护产品，重点是癌症辅助治疗中的抗感染产品、处方产品和间质干细胞疗法。 它有五种产品。 Mino-Lok, Mino-Wrap, Halo-Lido, NoveCite和I/ONTAK。 Mino-Lok是一种抗生素锁定溶液，通过挽救受感染的导管来治疗与导管有关的血流感染患者。 Mino-Wrap是一种基于液化凝胶的包膜，用于减少乳房整形手术后组织扩张器的感染。 Halo-Lido是一种皮质类固醇-利多卡因的外用制剂，旨在为患有痔疮的人提供消炎和麻醉缓解。 NoveCite是一种治疗ARDS的间质干细胞疗法。 I/ONTAK是一种工程化的IL-2白喉毒素融合蛋白，用于治疗顽固或复发的皮肤T细胞淋巴瘤患者。

    Industry: Biotechnology & Medical Research (NEC)

    11 Commerce Dr Fl 1
    CRANFORD
    NEW JERSEY 07016-3501
    US

    收入报表

    • Annual
    • Quarterly

    人们也观看

    XRP/USD

    0.51 Price
    -0.390% 1D Chg, %
    多头隔夜费 -0.0753%
    空头隔夜费 0.0069%
    隔夜费时间 21:00 (UTC)
    价差 0.00387

    US100

    14,445.90 Price
    +1.380% 1D Chg, %
    多头隔夜费 -0.0255%
    空头隔夜费 0.0032%
    隔夜费时间 21:00 (UTC)
    价差 1.8

    Gold

    1,975.35 Price
    +0.720% 1D Chg, %
    多头隔夜费 -0.0183%
    空头隔夜费 0.0101%
    隔夜费时间 21:00 (UTC)
    价差 0.30

    Oil - Crude

    70.30 Price
    +3.890% 1D Chg, %
    多头隔夜费 -0.0204%
    空头隔夜费 -0.0016%
    隔夜费时间 21:00 (UTC)
    价差 0.03

    还在找一位您可以信任的经纪商吗？

    加入成为全球535,000万多名交易者的一份子，选择利用Capital.com进行交易吧。

    1. 创建和验证您的账户 2. 进行存款 3. 找到适合您的交易